Prelude Therapeutics Inc

PRLD

Insider trades and stock quote 2024-2026

All insider trades at Prelude Therapeutics Inc

Subscribe RSS
Date Type Insider Position Ø-Price Volume
4/21/2026 Buy Orbimed Advisors LLC Director $4.4 $12,499,998
4/21/2026 Buy Bonita, David P. Director $4.4 $12,499,998
3/25/2025 Buy Vaddi, Krishna CEO $0.7 $467,438
3/25/2025 Buy Combs, Andrew Chief Chemistry Officer $0.7 $69,250
3/21/2025 Buy Vaddi, Krishna CEO $0.7 $10,959
3/20/2025 Buy Vaddi, Krishna CEO $0.7 $3,950
3/17/2025 Buy Vaddi, Krishna CEO $0.7 $6,829
3/14/2025 Buy Vaddi, Krishna CEO $0.8 $22,631
3/13/2025 Buy Vaddi, Krishna CEO $0.7 $35,820
3/12/2025 Buy Vaddi, Krishna CEO $0.7 $33,744
12/31/2024 Buy Vaddi, Krishna CEO $1.2 $6,044
12/30/2024 Buy Vaddi, Krishna CEO $1.2 $12,000
12/23/2024 Buy Combs, Andrew Chief Chemistry Officer $1.4 $82,002
12/20/2024 Buy Combs, Andrew Chief Chemistry Officer $1.2 $3,536
12/19/2024 Buy Vaddi, Krishna CEO $0.9 $6,116
12/19/2024 Buy Lim, Bryant David CLO, Interim CFO, Corp Sec. $0.9 $22,638
12/18/2024 Buy Vaddi, Krishna CEO $0.9 $93,210
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)